Join
Live feed
·
PRReleasevia Quantisnow
Talaris Therapeutics Inc. logo

New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
TALS· Talaris Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TALS (Talaris Therapeutics Inc.) and more on Quantisnow.